Download PDF
Aktuelle Neurologie 2015; 42(05): 270-273
DOI: 10.1055/s-0035-1552648
Debatte: Pro & Kontra
© Georg Thieme Verlag KG Stuttgart · New York

Hoch dosiertes Vitamin E beim Morbus Alzheimer – Pro

High Dose Vitamin E in Alzheimerʼs Disease – Pro
C. A. F. von Arnim
Neurologische Universitätsklinik Ulm
› Author Affiliations
Further Information

Publication History

Publication Date:
30 June 2015 (online)

Also available at
    Permissions and Reprints

Pro

Hintergrund und Epidemiologie

Die Alzheimer-Demenz (AD) ist eine neurodegenerative Erkrankung des höheren Lebensalters. Oxidative Schäden sind mit Alterungsprozessen assoziiert und finden sich bei der Alzheimer-Demenz im Hirngewebe. Durch Freisetzung freier Radikale kann es zu Schädigungen an Proteinen, Lipiden, Mitochondrien und DNA kommen und der Zellzyklus kann aktiviert werden.


#
 

  • Literatur

  • 1 Mangialasche F, Xu W, Kivipelto M et al. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging 2012; 33: 2282-2290
    CrossrefPubMedGoogle Scholar
  • 2 von Arnim CA, Herbolsheimer F, Nikolaus T et al. Dietary antioxidants and dementia in a population-based case-control study among older people in South Germany. J Alzheimers Dis 2012; 31: 717-724
    PubMedGoogle Scholar
  • 3 Hara H, Kogure K. Prevention of hippocampus neuronal damage in ischemic gerbils by a novel lipid peroxidation inhibitor (quinazoline derivative). J Pharmacol Exp Ther 1990; 255: 906-913
    PubMedGoogle Scholar
  • 4 Anderson DK, Waters TR, Means ED. Pretreatment with alpha tocopherol enhances neurologic recovery after experimental spinal cord compression injury. J Neurotrauma 1988; 5: 61-67
    CrossrefPubMedGoogle Scholar
  • 5 Yoshida S, Busto R, Watson BD et al. Postischemic cerebral lipid peroxidation in vitro: modification by dietary vitamin E. J Neurochem 1985; 44: 1593-1601
    CrossrefPubMedGoogle Scholar
  • 6 Behl C, Davis J, Cole GM et al. Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun 1992; 186: 944-950
    CrossrefPubMedGoogle Scholar
  • 7 Nishida Y, Yokota T, Takahashi T et al. Deletion of vitamin E enhances phenotype of Alzheimer disease model mouse. Biochem Biophys Res Commun 2006; 350: 530-536
    CrossrefPubMedGoogle Scholar
  • 8 Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. New Engl J Med 1997; 336: 1216-1222
    CrossrefPubMedGoogle Scholar
  • 9 Sano M, Ernesto C, Klauber MR et al. Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer’s Disease Cooperative Study. Alzheimer Dis Assoc Disord 1996; 10: 132-140
    CrossrefPubMedGoogle Scholar
  • 10 Miller 3rd ER, Pastor-Barriuso R, Dalal D et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37-46
    CrossrefPubMedGoogle Scholar
  • 11 Petersen RC, Thomas RG, Grundman M et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. New Engl J Med 2005; 352: 2379-2388
    CrossrefPubMedGoogle Scholar
  • 12 Dysken MW, Sano M, Asthana S et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014; 311: 33-44
    CrossrefPubMedGoogle Scholar
  • 13 Dysken MW, Guarino PD, Vertrees JE et al. Vitamin E and memantine in Alzheimer’s disease: clinical trial methods and baseline data. Alzheimer Dement 2014; 10: 36-44
    CrossrefPubMedGoogle Scholar